4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-017624
Director sold 33,244 shares at an average $31.90 ($1,060,518)
From the SEC's structured data for this filing
Trades in this filing
SCHAFFER DAVID · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-27 | Sale : show line 1 in the form | −13,075 | $32.59 | $426,076 | 986,925 | D |
| 2021-09-27 | Sale : show line 2 in the form | −6,157 | $33.51 | $206,330 | 980,768 | D |
| 2021-09-27 | Sale : show line 3 in the form | −100 | $34.19 | $3,419 | 980,668 | D |
| 2021-09-28 | Sale : show line 4 in the form | −13,812 | $30.52 | $421,493 | 966,856 | D |
| 2021-09-28 | Sale : show line 5 in the form | −100 | $32.00 | $3,200 | 966,756 | D |
| Open-market sales · 33,244 sh · avg $31.90 · $1,060,518 | ||||||
Loading xslF345X03/doc1.xml…